Advances in Experimental Medicine and Biology

Treatment of EARLY DIABETES

Editors: Camerini-Davalos, R. (Ed.)

Buy this book

eBook $69.99 net
( price for USA )
  • ISBN 978-1-4615-9110-8
  • digitally watermarked, no DRM
  • included format: PDF
  • eBooks can be used on all Reading Devices
Softcover $99.00 net
( price for USA )
  • ISBN 978-1-4615-9112-2
  • free shipping for individuals worldwide
  • usually dispatched within 3 to 5 business days
About this book

To obey the precepts of therapeutic rationality, we should avoid treating the "effect" when there is a way to attack the cause. But what is the cause of diabetes? Diabetes is a molecular disease, that is, a disease in which important cellular components are seriously impaired. Eventually, the activities or the products arising from the impairment find expression in various ways, finally culminating in the abnormalities of diabetes. How early is early enough to attempt to delay this sequence of events? What will provide us with the basis to explore ways and means of halting the progression of the pathological process? What are the new approaches for the treatment of early diabetes? The Fourth International Symposium on Early Diabetes, sponsored by the Diabetes Center of the New York Medical College, held in Algarve, Portugal in November 1978, from which this book evolved, attempted to answer some of these questions. A list of the participants, including their affiliations, will be found preceding the index. Rafael A. Camerini-Davalos v Acknowledgments To our sponsors, U.S.V. Pharmaceutical Corp., Pfizer Pharmaceuticals, Ames Company, Hoechst, Frankfurt; supporters, Boehringer, Manheim, Laboratoires Servier, Nordisk Laboratory, The Upjohn Company, Eli Lilly and Company, F. Hoffman La Roche; and contributors, Bayer A. G. Leverkusen, McNeil, Novo Research Institute, ICI Belgium, Hope for Diabetics Foundation, New York, we express our appreciation for the financial support which made possible the Fourth International Symposium on Early Diabetes. THE ORGANIZING COMMITTEE Rafael A. Camerini-Davalos, M.D.

Table of contents (3 chapter)

  • Refuting the UGDP Conclusion that Insulin Treatment does not Prevent Vascular Complications in Diabetes

    C. Kilo, J. R. Williamson, S. C. Choi, et al.

    Pages 307-311

    Buy Chapter $29.95
  • Diabetic Glomerulosclerosis in KK Mice and its Prevention by Glyburide and Pyridinolcarbamate

    R. A. Camerini-Davalos, A. S. Reddi, T. H. Ehrenreich, et al.

    Pages 387-398

    Buy Chapter $29.95
  • Gliclazide in the Treatment of Diabetic Retinopathy

    F. Regnault

    Pages 443-448

    Buy Chapter $29.95
Free Preview

Buy this book

eBook $69.99 net
( price for USA )
  • ISBN 978-1-4615-9110-8
  • digitally watermarked, no DRM
  • included format: PDF
  • eBooks can be used on all Reading Devices
Softcover $99.00 net
( price for USA )
  • ISBN 978-1-4615-9112-2
  • free shipping for individuals worldwide
  • usually dispatched within 3 to 5 business days

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Treatment of EARLY DIABETES
Series Title
Advances in Experimental Medicine and Biology
Series Volume
119
Copyright
1979
Publisher
Springer US
Copyright Holder
Springer Science+Business Media New York
eBook ISBN
978-1-4615-9110-8
DOI
10.1007/978-1-4615-9110-8
Softcover ISBN
978-1-4615-9112-2
Series ISSN
0065-2598
Edition Number
1
Topics